Catch up on the top radiology content of the past week.
|Articles|October 13, 2010
- Diagnostic Imaging Vol 32 No 9
- Volume 32
- Issue 9
MRI, MRS scans reveal who will lose weight
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes.
Advertisement
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes. Study subjects whose health improved the most after lifestyle changes started out with lower baseline levels of abdominal and liver fat.
German researchers performed MRI and MR spectroscopy on 243 individuals prior to and nine months after a lifestyle intervention (weight loss of 5%, reduced fat intake, and moderate physical activity). Each of the participants was considered at risk of developing type 2 diabetes as a result of obesity.
After nine months, insulin sensitivity improved in 71% of the men and 58% of the women. Individuals with improved insulin sensitivity lost significant amounts of abdominal fat (19% for women and 20% for men) and liver fat (35% for women and 44% for men) (Radiol doi:10.1148/radiol.10092284).
Articles in this issue
almost 16 years ago
Overlap shifts to help urgent findings communicationalmost 16 years ago
Spectral CT IDs heart plaque better than conventionalalmost 16 years ago
Cardiac MRI shows heart adaptations in triathletesalmost 16 years ago
Sheryl Crow teams up with breast cancer centeralmost 16 years ago
New meaningful use rules spell opportunity for radiologyalmost 16 years ago
Meaningful use: The government's billion dollar gift to radiologistsalmost 16 years ago
MSCT moves ahead of DSA for peripheral arterial diseasealmost 16 years ago
CT and MRI drive awareness of vascular liver disordersalmost 16 years ago
In a disaster, Homeland Security has plans for youalmost 16 years ago
In overutilization, some practices more culpableAdvertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5